As depicted in Figure 6b, ‘Pathway in Cancer’ contains the maximum number of targets (551 counts, Table S6), followed by ‘Pathways of Neurodegeneration—Multiple Diseases’ and the ‘PI3K-Akt Signaling Pathway’. This evidence concerns the gene AKT1 and cancer.